Literature DB >> 224691

The effect of a natural high-fiber diet on serum lipids, fecal lipids, and colonic function.

M Stasse-Wolthuis, J G Hautvast, R J Hermus, M B Katan, J E Bausch, J H Rietberg-Brussaard, J P Velema, J H Zondervan, M A Eastwood, W G Brydon.   

Abstract

In a cross-over experiment, 46 young healthy volunteers consumed in succession a high-fiber and a low-fiber diet for 3 weeks at two levels of dietary cholesterol. Half of the dietary fiber came from fruits and vegetables, and the rest from bread and other cereal products. On the high-fiber diet, concentrations of serum cholesterol decreased on average by 0.44 mmole/liter with high-cholesterol and 0.31 mmole/liter with low-cholesterol regimes; high density lipoprotein-cholesterole decreased by 0.1 mmole/liter; on average fecal weight increased by 115 g/day and mean transit time through the gut was decreased by 18 hr. Only part of the decrease in serum cholesterole may be due directly to the high intake of dietary fiber components. The remainder is due to differences in fat intake: during the high-fiber period subjects consumed less fat and cholesterol than had been planned.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224691     DOI: 10.1093/ajcn/32.9.1881

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.

Authors:  Wendy Demark-Wahnefried; Thomas J Polascik; Stephen L George; Boyd R Switzer; John F Madden; Mack T Ruffin; Denise C Snyder; Kouros Owzar; Vera Hars; David M Albala; Philip J Walther; Cary N Robertson; Judd W Moul; Barbara K Dunn; Dean Brenner; Lori Minasian; Philip Stella; Robin T Vollmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

2.  Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer.

Authors:  Wendy Demark-Wahnefried; Stephen L George; Boyd R Switzer; Denise C Snyder; John F Madden; Thomas J Polascik; Mack T Ruffin; Robin T Vollmer
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

3.  Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.

Authors:  Maria Azrad; Kui Zhang; Robin T Vollmer; John Madden; Thomas J Polascik; Denise C Snyder; Mack T Ruffin; Judd W Moul; Dean Brenner; Robert W Hardy; Wendy Demark-Wahnefried
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.